Seeking Alpha

ULGX
  Urologix, Inc. - NASDAQ

8/20/2014, 4:38 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ULGX vs. ETF Alternatives
Company Description
Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement also known as benign prostatic hyperplasia (BPH).